We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Urine Test Produces Antibiotic Susceptibility Results Directly

By LabMedica International staff writers
Posted on 10 Jul 2019
Antibiotic susceptibility testing, or AST, is a widely used method of evaluating antibiotic resistance and determining patient treatment plans in clinical settings. More...
There are a number of different methods of AST such as agar dilution, broth dilution and disc diffusion assays.

Empiric treatment is often started before laboratory microbiological reports are available when treatment should not be delayed due to the seriousness of the disease. The effectiveness of individual antibiotics varies with the location of the infection, the ability of the antibiotic to reach the site of infection, and the ability of the bacteria to resist or inactivate the antibiotic.

Microbiologists at the Groupe Hospitalier Paris-Saint-Joseph (Paris, France) collected urine samples were collected from 107 patients aged 52 to 80 years with urinary tract infections (UTIs) (ratio of females to males 2:1). The median C-reactive protein was 104 mg/L (range, 39-145). The urine specimens displayed a median leukocyturia of 380/mm3 (range, 192-1,497) and median bacteriuria of 106 colony forming units/mL (range, 105-107). Only gram-negative bacilli were evident on direct examination using microscopy.

A novel rapid method was performed by direct inoculation of urine on Mueller-Hinton Rapid-SIR (MHR-SIR) agar using a swab according to a standard protocol. The resulting inhibition zones were read from digital images after eight-hours of incubation and were interpreted using standard methods. Of 70 patients who were currently receiving antibiotic therapy, the results prompted a shift in therapy for 29 patients, with no modification for the remaining 41. The most commonly used antibiotics were third generation cephalosporins, followed by fluoroquinolones, beta-lactamase inhibitors, fosfomycin, and nitrofurantoin. The rapid results lead to treatment escalation in 7% of the patients and de-escalation in 30%. The average time to obtain results was 7.2 ± 1.6 hours, representing a time saving of 42.6 hours compared with the standard technique.

The team noted that the method was affordable, with an average cost of USD 6 per sample for 16 antibiotics chosen by a microbiologist. Benoît Pilmis, MD, an infectious disease specialist and a co-author of the study, said, “The diagnosis of urinary tract infection generally requires a 48-hour microbiological delay to obtain the antibiotic susceptibility test. In the context of multidrug resistance, reducing the time to obtain antibiotic susceptibility test results is an essential issue to avoid treatment failure. The rapidity of the results impact the therapeutic management of patients as it enables not only the prescription of the most relevant antibiotic, but also the reduction of the spectrum of antibiotic therapy.” The study was presented at Annual meeting of the American Society of Microbiology, held June 7-11, 2019, in Atlanta, GA, USA.

Related Links:
Groupe Hospitalier Paris-Saint-Joseph


New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The cell-based tests bring artificial intelligence to transplant outcome care (Photo courtesy of iStock)

AI-Enhanced Cell-Based Blood Tests to Improve Predictive Accuracy for Complex Transplant Outcomes

Managing immunosuppressive drugs in transplant patients is a delicate challenge. Insufficient medication can lead to rejection, which may be cell- or antibody-mediated, while excess immunosuppression raises... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: A saliva test can help predict future metabolic health concerns including diabetes and obesity (Photo courtesy of 123RF)

Saliva Test to Enable Early Detection of Diabetes and Obesity

Type 2 diabetes affects about 400 million people globally and is typically diagnosed through elevated blood glucose levels. However, conditions like insulin resistance and hyperinsulinemia may begin developing... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.